StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CONTILI.BO$22.71-3.36%
Fair $22.71+0.0%

CONTILI.BO

Contil India Limited

Consumer Defensive / Food DistributionBSE

$22.71

-0.79 (-3.36%)

Fairly Valued+0.0%Fair Value $22.71Fund rank 22/100 · Data gapFallback financials|
SA 27/D
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 15%

FCF escenarios

weak_data · normalized FCF $1.3M · quality 29.3/100

Data gap 22/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 15/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

27/100

D

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · CONTILI.BOLocal privado en este navegador · Contil India Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$351M

P/E

15.4x

↑

EV/EBITDA

10.3x

↑

ROE

21.9%

↑

Gross Margin

19.0%

↓

Debt/Equity

N/A

•
52-Week Range$23
$19$42

TradingView lightweight chart

CONTILI.BO price, volumen y niveles de valoración

Último $22.71Periodo +354.2%
Fair value: $22.71

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+24.9%

FCF CAGR

—

FCF margin

-1.2%

FCF / Net income

-0.16x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $325.7M · net income $25.3M · FCF $-4.0M

2022-FY → 2025-FY

Gross margin

19.0%+8.0% pts

Operating margin

8.1%+7.9% pts

Net margin

7.8%+4.1% pts

FCF margin

-1.2%+0.7% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$325.7M$325.7M$282.4M$196.7M$167.0M
Net Income$25.3M$25.3M$14.1M$6.2M$6.2M
EBITDA$34.0M$34.0M$20.4M$9.0M$8.0M
EPS1.631.634.560.400.40
Gross Margin19.0%19.0%13.3%15.2%11.1%
Operating Margin8.1%8.1%2.0%3.1%0.2%
Net Margin7.8%7.8%5.0%3.2%3.7%
Balance Sheet
Current Ratio5.355.35———
Cash Flow
Free Cash Flow$-4.0M$-4.0M$16.9M$1.3M$-3.3M
Returns
ROE21.9%21.9%14.7%8.5%9.2%
Valuation
P/E15.4515.4529.66203.16125.25
EV/EBITDA10.3310.33102.63140.4897.07
P/B3.053.0521.8917.1411.53
Growth & Yield
Revenue Growth15.3%15.3%43.6%17.8%—
EPS Growth-64.3%-64.3%1034.3%0.5%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

7.3%

razonable

EPS terminal req.

$2.02

Spread vs growth

-71.6%

5Y implied EPS CAGR

8.4%

razonable

EPS terminal req.

$2.44

Spread vs growth

-72.6%

10Y implied EPS CAGR

9.2%

razonable

EPS terminal req.

$3.93

Spread vs growth

-73.4%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -33.2%

Total return

-33.2%

Start / end P/E

7.5x → 13.9x

EPS bridge

4.56 → 1.63

Residual

-55.8%

EPS growth-64.3%
Multiple rerating+86.9%
Dividend+0.0%
Residual / FX / buybacks / cross-term-55.8%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.